Endothelin ET(B) receptors counteract venoconstrictor effects of endothelin-1 in anesthetized rats

Life Sciences

Volumn 63, Issue 14, 1998, Pages 1239-1249

  Palacios, Beatriz ^a   Lim, Su Lin ^a   Pang, Catherine C Y ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Endothelin receptor antagonist; Endothelin 1; ET(B) receptor agonist; Mean circulatory filling pressure; Venous resistance

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE];

ANIMAL EXPERIMENT; ARTERY DILATATION; ARTERY RESISTANCE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HEART OUTPUT; HORMONE RECEPTOR INTERACTION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; VEIN DILATATION; VEIN RESISTANCE; VENOCONSTRICTION; VENOUS RETURN;

ANESTHESIA; ANIMALS; ENDOTHELIN-1; ENDOTHELINS; HEMODYNAMIC PROCESSES; MALE; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; VASOCONSTRICTION; VEINS;

EID: 0344980136     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00386-5     Document Type: Article

References (39)

1. 1. G.A. GRAY and D.J. WEBB, Pharmacol. Ther. 72 109-148 (1996).
2. 2. M. CLOZEL, G.A. GRAY, V. BREU, B.-M. LÖFFLER and R. OSTERWALDER, Biochem. Biophys. Res. Commun. 186 867-873 (1992).
3. 3. M.J. SUMNER, T.R. CANNON, J.W. MUNDIN, D.G. WHITE and I.S. WATTS, Br. J. Pharmacol. 107 858-860 (1992).
4. 4. V.K. BATRA, J.R. McNEILL, Y. XU, T.W. WILSON and V. GOPALAKRISHNAN, Am. J. Physiol. 264 C479-C484 (1993).
5. 5. S.S. SHETTY, T. OKADA, R.L. WEBB, D. DelGRANDE and R.W. LAPPE, Biochem. Biophys. Res. Commun. 191 459-464 (1993).
6. 6. T.D. WARNER, G.H. ALLCOCK, R. CORDER and J.R. VANE, Br. J. Pharmacol. 110 777-782 (1993).
7. 7. J.G. FILEP, M. CLOZEL, A. FOURNIER and E. FÖLDES-FILEP, Br. J. Pharmacol. 113 845-852 (1994).
8. 8. S.M. GARDINER, P.A. KEMP, J.E. MARCH, T. BENNETT, A.P. DAVENPORT and L. EDVINSSON, Br. J. Pharmacol. 112 477-486 (1994).
9. 9. M.E. BEYER, G. SLESAK and H.M. HOFFMEISTER, J. Cardiovasc. Pharmacol. 26 (Suppl. 3) S190-S192 (1995).
10. 10. A.M. SHARIFI and E.L. SCHIFFRIN, Can. J. Physiol. Pharmacol. 74 934-939 (1996).
11. 11. J.G. FILEP, B. BATISTINI, Y.P. COTE, A.R., BEAUDOIN and P. SIROIS, Biochem. Biophys. Res. Commun. 177 171-176 (1991).
12. 12. Y. FUJITANI, H. UEDA, T. OKADA, Y. URADE and H. KARAKI, J. Pharmacol. Exp. Ther. 267 683-689 (1993).
13. 13. Y. HIRATA, T. EMORI, S. EGUCHI, K. KANNO, T. IMAI, K. OHATA and F. MARUMO, J. Clin. Invest. 91 1367-1373 (1993).
14. 14. H. KARAKI, S.A. SUDJARWO, M. HORI, M. TAKAI, Y. URADE and T. OKADA, Br. J. Pharmacol. 109 486-490 (1993).
15. 15. T. HIGASHI, T. ISHIZAKI, K. SHIGEMORI, T. YAMAMURA and T. NAKAI, Br. J. Pharmacol. 121 782-786 (1997)
16. 16. R.P. WAITE, S.L. LIM and C.C.Y. PANG, Br. J. Pharmacol. 116 2322-2326 (1995).
17. 17. B. PALACIOS, S.L. LIM and C.C.Y. PANG, Eur. J. Pharmacol. 327 183-188 (1997a).
18. 18. C.F. ROTHE, J. Appl. Physiol. 74 499-509 (1993).
19. 19. C.C.Y. PANG, The Effects of Drugs on the Venom System, 1-139, U.S.A. Medical Intelligence Unit, R.G. Landes Co, Austin, Texas (1994).
20. 20. B. PALACIOS, S.L. LIM and C.C.Y. PANG, Br. J. Pharmacol. 122 993-998 (1997b).
21. 21. K. ISHIKAWA, M. IHARA, K. NOGUCHI, T. MASE, N. MINO, T. SAEKI, T. FUKURODA, T. FUKAMI, S. OZAKI, T. NAGASE, M. NISHIKIBE and M. YANO, Proc. Natl. Acad. Sci. 91 4892-4896 (1994).
22. 22. G.H. ALLCOCK, T.D. WARNER and J.R. VANE, Br. J. Pharmacol. 116 2482-2486 (1995).
23. 23. D.A. FLYNN, C.A. SARGENT, R. BRAZDIL, T.J. BROWN and A.G. ROACH, J. Cardiovasc. Pharmacol. 26 (Suppl. 3) S219-S221 (1995).
24. 24 C.A. SARGENT, R. BRAZDIL, D.A. FLYNN, T.J. BROWN and A.G. ROACH, J. Cardiovasc. Pharmacol. 26 (Suppl. 3) S216-S128 (1995).
25. 25. H. KARAKI, S.A. SUDJARWO and M. HORI, Biochem. Biophys. Res. Commun. 205 168-173 (1994).
26. 26. Y.-X. WANG, S.L. LIM and C.C.Y. PANG, Br. J. Pharmacol. 114 1454-1458 (1995).
27. 27. R. TABRIZCHI and C.C.Y. PANG, Cardiovasc. Res. 26 443-448 (1992).
28. 28. R. TABRIZCHI, S.L. LIM and C.C.Y. PANG, Am. J. Physiol. 264 H259-H261 (1993).
29. 29. C.V. GREENWAY and W.W. LAUTT, Hepatic Circulation. In: The Gastrointestinal System, Motility and Circulation, Handbookof Physiology, Am. Physiol. Soc., Bethesda: Section 6, Vol. 1, Part 2, Chap. 41:1519-1564 (1989).
30. 30. R. TABRIZCHI, S.L. LIM and C.C.Y. PANG, Am. J. Physiol. 264 H259-261 (1993).
31. 31. R.L. WEBB, A.E. NAVARRETE and G.M. KSANDER, J. Cardiovasc. Pharmacol. 26 (Suppl. 3) S389-S392 (1995).
32. 32. M. GELLAI, T. FLETCHER, M. PULLEN and P. NAMBI, Am. J. Physiol. 271 R254-R261 (1996).
33. 33. M. CIRINO, E. MARTIN, M. YANO, I.W. RODGER, J. Cardiovasc. Pharmacol. 29 704-712 (1997).
34. 34. G.H. ALLCOCK, T.D. WARNER, J. Cardiovasc. Pharmacol. 26 (Suppl. 3) S177-179 (1995).
35. 35. T. MATSUURA, T. YUKIMURA, S. KIM,. K. MIURA, H. IWAO, Jap. J. Pharmacol. 71 213-222 (1996).
36. 36. M.C. MAURICE, J.P. GRATTON and P. D'ORLEANS-JUSTE, Br. J. Pharmacol. 120 319-325 (1997).
37. 37. K. SATO, M. OKA, K. HASUNUMA and M. OHNISHI, et al. Am. J. Physiol. 269 L668-L672 (1995).
38. 38. M. MURAMATSU, D.M. RODMAN, M. OKA and I.F. MCMURTRY, Am J Physiol. 272 L807-12 (1997).
39. 39. J. DUPUIS, C.A. GORESKY and A. FOURNIER, J Applied Physiol. 81 1510-1515, (1996).